Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
D000284:Administration, Oral; D000758:Anesthesia / Q000009:adverse effects*; D002648:Child; D003620:Dantrolene / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology / Q000235:genetics* / Q000517:prevention & control; D011229:Preanesthetic Medication
D003620:Dantrolene